P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY PROFILE AND COMPARISON WITH IBRUTINIB PROFILE IN PATIENTS WITH B-CELL MALIGNANCIES: POST HOC ANALYSIS OF A LARGE CLINICAL TRIAL SAFETY DATABASE

Bibliographic Details
Title: P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY PROFILE AND COMPARISON WITH IBRUTINIB PROFILE IN PATIENTS WITH B-CELL MALIGNANCIES: POST HOC ANALYSIS OF A LARGE CLINICAL TRIAL SAFETY DATABASE
Authors: Jennifer R. Brown, Barbara Eichhorst, Paolo Ghia, Wojciech Jurczak, Brad Kahl, Nicole Lamanna, Tadeusz Robak, Mazyar Shadman, Constantine Tam, Lugui Qiu, Aileen Cohen, Meng Zhang, Tommi Salmi, Jason Paik, Liping Wang, Jun Zhang, Han MA, Alessandra Tedeschi
Source: HemaSphere, Vol 7, p e356884b (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2572-9241
Relation: http://journals.lww.com/10.1097/01.HS9.0000969428.35688.4b; https://doaj.org/toc/2572-9241
DOI: 10.1097/01.HS9.0000969428.35688.4b
Access URL: https://doaj.org/article/a47925ffc1eb490ca2450c096edf323d
Accession Number: edsdoj.47925ffc1eb490ca2450c096edf323d
Database: Directory of Open Access Journals
More Details
ISSN:25729241
DOI:10.1097/01.HS9.0000969428.35688.4b
Published in:HemaSphere
Language:English